Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists

Tata, Vaishnavi; Varisco, Tyler J.; Du, Nathan; Nguyen, Jonathan; Haghparast, Parna; Thornton, J. Douglas

doi:10.1016/j.japh.2021.01.010

Cited by 3 publications

(6 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The extracted data from the included studies were then classified into main conceptual categories and summarised to align with the scoping review objective and research questions. The data extraction results are presented in Tables S1 and S2 [18–166], Supporting Information.…”

Section: Resultsmentioning

confidence: 99%

“…Overall, half of the studies involved patients [9,18,22–24,26,27,32,34,36–38,41–43,45,46,48,50,53,54,59,62,63,65,66,71,73,75,77–80,84–86,88,90,93,95,97,98,100,101,104,105,108–110,115–118,121,123,125,130,131,134,140,144,146,147,149,151,152,154–156,158,159,161,163,165,167] and 47% included health‐care providers [11,19,20,25,29,30,33,35,37,39,40,43,44,49,51,54–61,67–69,71,72,74,76,80–83,87,91,93,94,96,102,103,106,111–114,119,120,122,124,125,127,128,130,132,133,136–139,141,143,145,147,148,150,153,157,160,162,165]. Some studies included both patient and provider populations [36, 37, 54, 59, 80, 93, 130, 147, 166].…”

Section: Resultsmentioning

confidence: 99%

“…A total of 94 of the 153 retrieved studies were published between 2018 and 2020, with 16 studies published in 2021 [11,37,40,45,60,67,73,75,78,94,105,141,[150][151][152]154]. The majority of studies originated from the USA, with only four Canadian studies [11,107,145,158] and one Malaysian study included in this scoping review [21].…”

Section: Characteristics Of Research Publications: Year Of Publicatio...mentioning

confidence: 99%

“…Overall, half of the studies involved patients [9,18,[22][23][24]26,27,32,34,[36][37][38][41][42][43]45,46,48 [111][112][113][114]119,120,122,124,125,127,128,130,132,133,[136][137][138][139]141,143,145,147,148,150,153,157,160,162,165]. Some studies included both patient and provider populations [36,37,54,59,…”

Section: Study Populationsmentioning

confidence: 99%

“…Almost one-third of the studies (30%) described PDMPs as a risk mitigation tool. The clinical practice implications included improving prescribing practices (18%), supporting clinical decision making (12%) [21,31,47,51,55,58,60,71,74,80,100,112,114,119,126,135,140,143,150] and optimising clinical practice (9%). A minority of studies discussed how information from PDMPs facilitate drug misuse education with patients (8%) and health-care professional collaboration (6%).…”

Section: Research Themesmentioning

confidence: 99%

See 4 more Smart Citations

Mapping the research addressing prescription drug monitoring programs: A scoping review

Hoppe

Karimi

Khalil

2022

Drug and Alcohol Review

View full text Add to dashboard Cite

Issues. Prescription drug monitoring programs are a harm minimisation intervention and clinical decision support tool that address the public health concern surrounding prescription drug misuse. Given the large number of studies published to date and the ongoing implementation of these programs, it is important to map the literature and identify areas for further research to improve practice. Approach. A scoping review was undertaken to identify the research on prescription drug monitoring programs published between January 2015 and April 2021. Key Findings. A total of 153 citations were included in this scoping review. The majority of the studies originated from the USA and were quantitative. Results on program effectiveness are mixed and mainly examine their association with opioid-related outcomes. Unintended consequences are revealed in the literature and this review also highlights barriers to program use. Implications. Overall, findings are mixed despite the large number of studies published to date. Mapping the literature identifies priority areas for further research that can advise policymakers and clinicians on practice improvement. Conclusion. Results on prescription drug monitoring program effectiveness are mixed and mainly examine their association with opioid-related outcomes. This review highlights barriers to prescription drug monitoring program effectiveness related to program use and system integration. Further research is needed in these areas to improve prescription drug monitoring program use and patient outcomes.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Characteristics Of Research Publications: Year Of Publicatio...mentioning

confidence: 99%

Section: Study Populationsmentioning

confidence: 99%

Section: Research Themesmentioning

confidence: 99%

See 3 more Smart Citations

Mapping the research addressing prescription drug monitoring programs: A scoping review

Hoppe

Karimi

Khalil

2022

Drug and Alcohol Review

View full text Add to dashboard Cite

show abstract

Scoring the Value Assessment Framework for China: A Factorial Survey

Zhang,

Yang,

Bao

et al. 2024

Value in Health

View full text Add to dashboard Cite

Healthcare practitioner use of real-time prescription monitoring tools: an online survey

2023

View full text Add to dashboard Cite

Objective The aim of this study is to investigate how healthcare practitioners use real-time prescription monitoring tools in clinical practice. Methods An online survey was distributed to Australian prescribers and pharmacists who use a real-time prescription monitoring tool. Data were analysed and descriptive statistics summarised participant characteristics and responses. A Chi-squared test was conducted to test the difference between prescribers and pharmacists. Results The majority of participants agreed that real-time prescription monitoring (RTPM) information is useful (92.2%) and the tool is valuable for informing clinical decisions (90.2%); however, just over half reported that they had changed their prescribing or dispensing practices as a result of RTPM information (51.0%), and they employed evidence-based clinical interventions to varying degrees. No statistically significant differences were detected between pharmacists and prescribers and perceptions on tool use. Conclusions This is the first known study to investigate practitioner use of RTPM tools in Australia, and is a starting point for further research. What constitutes ‘success’ in the clinical application of RTPM tools is yet to be realised.

show abstract

Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists

Cited by 3 publications

References 29 publications

Mapping the research addressing prescription drug monitoring programs: A scoping review

Mapping the research addressing prescription drug monitoring programs: A scoping review

Scoring the Value Assessment Framework for China: A Factorial Survey

Healthcare practitioner use of real-time prescription monitoring tools: an online survey

Contact Info

Product

Resources

About